不安障害に対する無誘導,トランス診断,ウェブベースの介入の有効性 - ランダム化制御試験

Anna Baumeister¹, Lea Schuurmans¹, Steffen Moritz¹

¹University Medical Center Hamburg-Eppendorf, Department of Psychiatry and Psychotherapy, Germany.

Internet interventions

|August 21, 2025

まとめ

インターネットベースの認知行動療法 (iCBT) は,不安や関連する症状を効果的に軽減しました. しかし,すでに心理療法を受けている患者では,iCBTの追加的な効果は示されなかった.

科学分野:

精神的な健康
精神科
デジタル・セラピー

背景:

不安障害は非常に一般的ですが,重要な障壁のために治療が不足しています.
インターネットベースの認知行動療法 (iCBT) は治療のギャップを埋めるための拡張可能な解決策を提供します
非誘導ICBTは特に研究が不足している.

研究の目的:

不安および関連症状に対する6週間のトランス診断的無誘導ICBT介入を評価する.
通常の治療と比較してiCBTの有効性を評価する.
治療効果の潜在的緩和剤を探求する.

主な方法:

318人の参加者を対象としたランダム化制御試験で,無誘導のICBTと待機リストの対照群を比較した.
一次的 (不安) および二次的アウトカムにおける変化を評価するために,コヴァリアンス分析 (ANCOVA) が使用された.
二次的な結果はストレス,うつ,生活の質,自尊心でした

主要な成果:

iCBT群は,対照群と比較して,不安,ストレス,うつ病の有意な減少を示した (小から中程度の効果サイズ).
心理療法の併用は,iCBTの治療効果をマイナスにすることが判明しました.
同時期に従来の心理療法を受けた参加者には,iCBTの追加効果は観察されなかった.

結論:

無指導のICBTプログラムは,標準的なケアと比較して,不安と関連する症状を効果的に軽減します.
iCBTは既に従来の心理療法を受けている人たちに追加的な利益をもたらすようには見えません.
併用心理療法の患者に対するiCBTの役割を理解するために,さらなる調査が必要である.

キーワード:

不安についてインターネットによる介入自己啓発特定の恐怖症

さらに関連する動画

08:17

Reducing State Anxiety Using Working Memory Maintenance

Published on: July 19, 2017

7.6K

08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.3K

関連する概念動画

01:22

Behavior Therapy

106

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

106

01:30

Generalized Anxiety Disorder

203

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...

203

01:18

Anxiety: Overview

344

Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.

344

01:24

Treatment Strategies for Psychological Disorders

267

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...

267

01:25

Cognitive Therapy

269

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...

269

01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

1.2K

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...